Prelude Therapeutics Incorporated
$3.820
USD
Last updated on --.
24h volume220.94K
24h highest4.0600 USD
24h lowest3.7418 USD
24h Price movement-6.37%
PRLD recent prices
24 Hours
-6.37%-$0.26
30 days
-27.17%-$1.399
60 days
-14.75%-$0.649
90 days
+21.39%+$0.661
Key data
Previous close4.0800 USD
Market cap312.21M USD
Volume220.94K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.98000 USD
Net income (FY)-77.80M USD
Revenue (FY)16.72M USD
Last report dateMay 12, 2026
About Prelude Therapeutics Incorporated
HeadquartersWILMINGTON
Employees (FY)79.00
Revenue per employee (FY)211.65K USD
Net income per employee (FY)-984.78K USD
Listed onNasdaq
PRLD conversion tables
 |  |
|---|---|
| 0.5 PRLD | 1.910 USD |
| 1 PRLD | 3.820 USD |
| 5 PRLD | 19.1 USD |
| 10 PRLD | 38.2 USD |
| |
|---|---|
| 0.5 USD | 0.13089 PRLD |
| 1 USD | 0.26178 PRLD |
| 5 USD | 1.308 PRLD |
| 10 USD | 2.617 PRLD |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PRLD is trading at $3.820, -6.37% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PRLD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PRLD is currently trading at $3.820, -6.37% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PRLD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PRLD's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PRLD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PRLD's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Prelude Therapeutics Incorporated's market cap is currently 312.21M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume220.94K
24h highest4.0600 USD
24h lowest3.7418 USD
24h Price movement-6.37%
Start trade with PRLD Perpetual
Sign up to trade